Enodia Therapeutics

Enodia Therapeutics is a biotech company in Paris, France, founded in 2025. It has raised $25.0M across 1 round, most recently a $25.0M Seed in January 2026.

A new approach for targeted protein degradation

Headquarters
Paris
Employees
1–10
Founded
2025
Business Model
B2B
Total Funding
$25.0M
Last Round
$25.0M SeedJan 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 7 investors for this company. The full record is or through the API.

About

Enodia Therapeutics is a French biotechnology company developing best-in-class small-molecule therapies that target the Sec61 translocon — a novel mechanism enabling degradation of disease-related proteins at the point of synthesis, before they exert pathological effects. Founded in 2025 and originating from foundational research at the Institut Pasteur under Prof. Caroline Demangel, the company was created and incubated by Argobio Studio. Enodia's initial therapeutic focus is inflammatory and autoimmune diseases, targeting previously undruggable secreted and membrane proteins. The company raised €20.7M in early 2026 to advance its targeted protein degradation platform.

Summary

It lists 1–10 employees. It has raised $25.0M in total across 1 round, most recently a $25.0M Seed round in Jan 2026. Investors include Elaia, Pfizer Ventures and Bpifrance.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundJan 2026
$25.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Enodia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/enodia-therapeutics"><img src="https://indexed.vc/api/badge/company/enodia-therapeutics" alt="Enodia Therapeutics on Indexed.vc" width="260" height="76" /></a>